Compare Sanofi India with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs J.B.CHEMICALS - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA J.B.CHEMICALS SANOFI INDIA/
J.B.CHEMICALS
 
P/E (TTM) x 40.0 45.9 87.0% View Chart
P/BV x 8.1 8.5 95.2% View Chart
Dividend Yield % 1.1 0.1 778.3%  

Financials

 SANOFI INDIA   J.B.CHEMICALS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
J.B.CHEMICALS
Mar-18
SANOFI INDIA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs6,840363 1,883.8%   
Low Rs4,630255 1,815.7%   
Sales per share (Unadj.) Rs1,203.1169.1 711.3%  
Earnings per share (Unadj.) Rs165.316.6 995.6%  
Cash flow per share (Unadj.) Rs209.923.4 896.2%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.6 226.3%  
Book value per share (Unadj.) Rs963.6172.5 558.6%  
Shares outstanding (eoy) m23.0383.57 27.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.81.8 260.9%   
Avg P/E ratio x34.718.6 186.4%  
P/CF ratio (eoy) x27.313.2 207.1%  
Price / Book Value ratio x6.01.8 332.2%  
Dividend payout %50.812.0 421.9%   
Avg Mkt Cap Rs m132,07825,827 511.4%   
No. of employees `0003.33.8 87.5%   
Total wages/salary Rs m4,0682,511 162.0%   
Avg. sales/employee Rs Th8,393.83,747.4 224.0%   
Avg. wages/employee Rs Th1,232.4665.7 185.1%   
Avg. net profit/employee Rs Th1,153.0367.8 313.5%   
INCOME DATA
Net Sales Rs m27,70814,135 196.0%  
Other income Rs m897366 245.2%   
Total revenues Rs m28,60514,501 197.3%   
Gross profit Rs m6,2352,178 286.2%  
Depreciation Rs m1,027570 180.3%   
Interest Rs m735 20.1%   
Profit before tax Rs m6,0981,940 314.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292552 415.0%   
Profit after tax Rs m3,8061,387 274.4%  
Gross profit margin %22.515.4 146.0%  
Effective tax rate %37.628.5 132.0%   
Net profit margin %13.79.8 140.0%  
BALANCE SHEET DATA
Current assets Rs m15,92210,470 152.1%   
Current liabilities Rs m6,2352,749 226.8%   
Net working cap to sales %35.054.6 64.0%  
Current ratio x2.63.8 67.0%  
Inventory Days Days6455 115.3%  
Debtors Days Days2178 26.9%  
Net fixed assets Rs m7,5395,811 129.7%   
Share capital Rs m230167 137.6%   
"Free" reserves Rs m21,96214,248 154.1%   
Net worth Rs m22,19214,416 153.9%   
Long term debt Rs m00-   
Total assets Rs m29,83917,649 169.1%  
Interest coverage x872.156.6 1,541.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.8 115.9%   
Return on assets %12.88.1 158.6%  
Return on equity %17.29.6 178.2%  
Return on capital %27.513.7 200.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,5876,164 123.1%   
Fx outflow Rs m7,1451,334 535.4%   
Net fx Rs m4424,829 9.2%   
CASH FLOW
From Operations Rs m3,7391,231 303.9%  
From Investments Rs m-731-208 351.3%  
From Financial Activity Rs m-1,972-595 331.3%  
Net Cashflow Rs m1,036427 242.6%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 60.4 0.3 20,133.3%  
Indian inst/Mut Fund % 14.4 3.4 424.8%  
FIIs % 14.6 3.9 374.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 37.0 28.4%  
Shareholders   15,184 30,437 49.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   FULFORD INDIA  SUVEN LIFE SCIENCES  WYETH  CADILA HEALTHCARE  VENUS REMEDIES  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Higher, Dow Futures Up by 86 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 379 points, up 0.8% at 49,585 levels.

Related Views on News

CADILA HEALTHCARE at All Time High; BSE HEALTHCARE Index Up 1.9% (Market Updates)

May 10, 2021 | Updated on May 10, 2021

CADILA HEALTHCARE share price has hit an all time high at Rs 625 (up 3.4%). The BSE HEALTHCARE Index is up by 1.9%. Among the top gainers in the BSE HEALTHCARE Index today are CADILA HEALTHCARE (up 3.4%) and ABBOTT INDIA (up 1.0%). The top losers include J.B.CHEMICALS (down 0.4%) and GSK PHARMA (down 0.4%).

SANOFI INDIA Announces Quarterly Results (2QFY21); Net Profit Up 5.0% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 5.0% YoY). Sales on the other hand came in at Rs 7 bn (down 11.9% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY21); Net Profit Up 39.9% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, SANOFI INDIA has posted a net profit of Rs 1 bn (up 39.9% YoY). Sales on the other hand came in at Rs 7 bn (down 5.0% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY20); Net Profit Down 8.1% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, SANOFI INDIA has posted a net profit of Rs 854 m (down 8.1% YoY). Sales on the other hand came in at Rs 8 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


May 10, 2021 01:49 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS